Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 12/20 | 0.68 |
| ▸ | CES2 | O00748 | 11/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | DAO | P14920 | 1/20 | 0.52 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6520575 | 1.00 | CES1 (0.68) | CES1CES2ALDH1A1TSHRDAO | |
| Water SCHEMBL10351087 | 0.97 | CES1 (0.65) | CES1CES2ALDH1A1TSHRDAO | |
| Benzil SCHEMBL35210470 | 0.86 | CES2 (0.82) | CES1CES2ALDH1A1TSHRDAO | |
| SCHEMBL3686005 | 0.84 | CES1 (0.62) | CES1CES2ALDH1A1TSHRDAO | |
| SCHEMBL8438961 | 0.83 | CES2 (0.68) | CES1CES2ALDH1A1TSHRDAO | |
| SCHEMBL8912371 | 0.82 | CES1 (0.59) | CES1CES2ALDH1A1TSHRDAO | |
| Benzil SCHEMBL66 | 0.82 | CES2 (1.00) | CES1CES2ALDH1A1TSHRDAO | |
| Benzil SCHEMBL2156589 | 0.82 | CES2 (1.00) | CES1CES2ALDH1A1TSHRDAO | |
| Benzil SCHEMBL7142843 | 0.82 | CES2 (1.00) | CES1CES2ALDH1A1TSHRDAO | |
| Benzil SCHEMBL9517636 | 0.82 | CES2 (1.00) | CES1CES2ALDH1A1TSHRDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113750968-B | Water-insoluble cyclodextrin-based metal organic framework material and preparation method thereof | 东华大学 | 2022-11-11 | — | — | CN | claimed |
| CN-115335139-A | Dual-continuous high-through polymer ultrafiltration membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-112619420-A | Loofah sponge modified composite reverse osmosis membrane and preparation method thereof | 天津天元新材料科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| CN-111607838-A | Slow-release aromatic polyester fiber and preparation method thereof | 邓颖菁 | 2020-09-01 | — | — | CN | claimed |
| EP-3568231-A1 | REMOVING METAL IONS FROM AQUEOUS SYSTEMS WITH AN ACTIVE LAYER MEMBRANE | BASF SE (DE) | 2019-11-20 | — | — | EP | claimed |
| CN-106810411-B | A kind of method of acyl chlorides and 1,2- dichloroethanes reaction generation ester | 中国科学院大连化学物理研究所 | 2018-09-04 | — | — | CN | claimed |
| CN-107814736-A | Prepare N, the method for N dipropyl m-methyl benzamides | 天津市化学试剂研究所有限公司 | 2018-03-20 | — | — | CN | claimed |
| US-20170369445-A1 | a-KETOACYLIC ISONIAZID COMPOUNDS, PROCESS FOR PRODUCING SAID COMPOUNDS, USE OF THE COMPOUNDS IN THE TREATMENT OF TUBERCULOSIS | Fundação Oswaldo Cruz (Fiocruz) (BR) | 2017-12-28 | — | — | US | claimed |
| CN-104945209-B | A kind of synthetic method of 2-aminobutene 1,4-derovatives | 常州大学 | 2016-06-29 | — | — | CN | claimed |
| CN-104945209-A | Synthesizing method for 2-amino butene 1,4-diketone derivative | UNIV CHANGZHOU | 2015-09-30 | — | — | CN | claimed |
| EP-2701831-A1 | COMPOSITE MEMBRANES COMPRISING A SULFONATED POLYARYLETHER AND THEIR USE IN FORWARD OSMOSIS PROCESSES | BASF SE (DE) | 2014-03-05 | — | — | EP | claimed |
| WO-2012146629-A1 | COMPOSITE MEMBRANES COMPRISING A SULFONATED POLYARYLETHER AND THEIR USE IN FORWARD OSMOSIS PROCESSES | BASF SE (DE) | 2012-11-01 | — | — | WO | claimed |
| CN-101100461-B | Thiadiazole derivative for vulcanizing and crosslinking halogen-containing polymer and synthetic method thereof | PENGCHENG REN | 2012-04-18 | — | — | CN | claimed |
| JP-10045724-A | — | — | None | — | — | JP | disclosed |
| JP-3031324-A | — | — | None | — | — | JP | disclosed |
| JP-3031323-A | — | — | None | — | — | JP | disclosed |
| US-4024296-A | Photocatalyst system and pigmented actinic light polymerizable coating compositions containing the same | PPG INDUSTRIES, INC. (US) | 1977-05-17 | — | — | US | disclosed |
| US-4018818-A | Hydroxyl-substituted 2-chloro-α-(tert-butylaminomethyl)-benzylalcohols | HOKURIKU PHARMACEUTICAL CO., LTD. (JA) | 1977-04-19 | — | — | US | disclosed |
| US-4013658-A | SYNTHESIS OF 3,5-DIPHENYL-4(1H)-PYRIDAZINONES | ELI LILLY AND COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
| US-3967952-A | HERBICIDES | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170369445-A1 | a-KETOACYLIC ISONIAZID COMPOUNDS, PROCESS FOR PRODUCING SAID COMPOUNDS, USE OF THE COMPOUNDS IN THE TREATMENT OF TUBERCULOSIS | COASY, HMGCR, ACACB | CES1 542/4885CES2 983/4885ALDH1A1 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.